The PI3K-Akt signalling pathway has also been implicated in the development of neuropathic pain and hyperalgesia in sciatic nerve ligation models, diabetic neuropathy, bone cancer pain, spinal cord injury and inflammatory pain (Chen et al., 2017). The gene discussed is AKT1; the disease is bone neoplasm.